Trial Profile
17-Alpha-Hydroxyprogesterone Caproate for Reduction of Neonatal Morbidity Due to Preterm Birth in Twin and Triplet Pregnancies - A Concurrent Randomized Double-blinded Clinical Trial.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Hydroxyprogesterone (Primary)
- Indications Preterm birth
- Focus Therapeutic Use
- 05 Jun 2012 Additional lead trial investigator (Lee R) added as reported by ClinicalTrials.gov.(Extension trial: NCT00156000).
- 05 Jun 2012 Additional lead trial investigator (Lee R) added as reported by ClinicalTrials.gov.(Extension trial: NCT00156000).
- 06 Oct 2010 Actual end date (August 2009) added as reported by ClinicalTrials.gov.